Posts

Showing posts matching the search for HIV Treatment Lagging in West Africa

HIV Treatment Lagging in West Africa

HIV Treatment Lagging in West Africa  - The prevalence of HIV /AIDS is relatively low in West Africa compared to the rest of Africa , but treatment rates there are equally low, say activists and ...

Every day, 170 young people are infected with HIV in West and Central Africa, and many can't ...

Image
Every day, 170 young people are infected with HIV in West and Central Africa, and many can't ... - In recent years, almost five times as much money was invested in HIV /AIDS response in eastern and southern Africa than in West and Central Africa, creating a disparity that has left West and Central Africa lagging behind on both treatment and prevention. Many young people now dying of AIDS in the ... Android Chrome Windows Mobile friendly AppsCenter

Major health stories in the news last week

Major health stories in the news last week - UNICEF warned that the West and Central Africa were lagging too far behind the rest of the world in access to HIV treatment and care as four in five children living with HIV in the regions were still not receiving life-saving antiretroviral therapy. Also AIDS-related deaths among adolescents aged 15 to 19 ...

Africa framework for intra-governmental action to end Aids, TB and malaria

Africa framework for intra-governmental action to end Aids, TB and malaria - While there has been significant progress in the reduction of deaths and new rates of HIV infection, the West and Central Africa region is lagging behind. An emergency plan is needed urgently to accelerate the HIV response. Furthermore, despite the progress made, deaths and new infection rates remain high among young people especially young girls and women and more concerted efforts and investments are needed to address the their unmet needs. The situation is made worse by under investments in tuberculosis that have hampered efforts for increased coverage and access to services for detection and treatment. Furthermore, the gains against malaria are fragile and require additional investments for antimalarial drug and insecticide resistance monitoring, giving priority to surveillance, detection and response.